, Singapore
156 views
Photo from Pexels by Ksenia Chernaya

DISA deploys automated vision screening test at SG clinic

The device provides accurate visual acuity testing that can be performed by patients.

DISA Limited’s subsidiary Digital Life Line (DLL) has deployed its Automated Visual Acuity Test (AVAT) devices at a hospital ophthalmology clinic in Singapore from 3 February 2025 to 2 February 2026.

The company said the device provides accurate visual acuity (VA) testing that can be performed by patients themselves without supervision by incorporating a familiar number pad input with audio confirmation.

AVAT also utilises a proprietary afocal optics system to recapitulate the current 6-metre test in 0.5 meters, which rules out the effects of positioning variation on test outcomes.

In a study conducted in September 2023 with 365 patients (of which, 32% were above the age of 60), the VA scores of AVAT and the manual test method were highly correlated.

Based on the criteria of VA 6/12 or worse which is used to determine additional testing with a pinhole occluder, AVAT correctly identified 163 of 168 patients, representing 97% sensitivity. In a follow-up satisfaction survey, 81.6% of patients expressed a preference for AVAT.

Under the contract, DLL will supply AVAT on a leasing basis, charging a fixed monthly rental fee along with a per-test fee.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.